TIMP-3 as a therapeutic target for cancer
Tissue inhibitor of metalloproteinase-3 (TIMP-3), a secreted glycoprotein, plays an important role in carcinogenesis. It can bind to many proteinases to suppress their activity and thus protect the extracellular matrix from degradation. TIMP-3 may have many anticancer properties, including apoptosis...
Main Authors: | Chun-Wen Su, Chiao-Wen Lin, Wei-En Yang, Shun-Fa Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835919864247 |
Similar Items
-
Characterisation and therapeutic targeting of TIMP3 in Sorsby's fundus dystrophy
by: Mujamammi, Ahmed Hussain A.
Published: (2013) -
TIMP3 promoter methylation and its role in oral cancer metastasis
by: Chun-Wen Su, et al.
Published: (2016) -
The use of a novel TIMP3 peptide to specifically target therapeutic drugs to tumours
by: Aldughaim, Mohammed
Published: (2017) -
Long Noncoding RNA BC032913 as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3
by: Jiaxin Lin, et al.
Published: (2017-09-01) -
Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
by: Manuel Abreu, et al.
Published: (2020-05-01)